Screener
GeneDx Holdings WGS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
Based on trailing twelve months.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
FAQ
- What is GeneDx Holdings's return on equity?
- GeneDx Holdings (WGS) reported return on equity of -30.4% in Q1 2026.
- What is the long-term trend for GeneDx Holdings's return on equity?
- Over 2 years (2022 to 2025), GeneDx Holdings's return on equity has grown at a -78.9% compound annual growth rate (CAGR), from -171.1% to -7.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about GeneDx Holdings's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude